---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-041188"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:37:11.637363+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Roivant shareholders re-elect three Class III directors, ratify EY auditor, approve say-on-pay annually

## Summary
- Directors Ilan Oren, James Momtazee, Dr. Mayukh Sukhatme re-elected with 68%-92% of votes cast.
- Ernst & Young ratified as independent auditor for FY2025; 679M for, 0.8M against.
- Non-binding advisory vote on executive compensation approved: 540M for, 64.5M against.
- Advisory vote frequency set to every one year (600.7M votes); company will hold annual say-on-pay votes.

## SEC filing metadata
- accession: 0001140361-24-041188
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036124041188/0001140361-24-041188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036124041188/ef20035923_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-041188
- JSON: https://secwatch.observer/filing/0001140361-24-041188.json
- Plain text: https://secwatch.observer/filing/0001140361-24-041188.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.